{"nctId":"NCT00189306","briefTitle":"Open-label Study to Evaluate Clearance of Superficial Basal Cell Carcinoma After Use of Imiquimod 5% Cream","startDateStruct":{"date":"2001-03"},"conditions":["Superficial Basal Cell Carcinoma"],"count":169,"armGroups":[{"label":"Aldara","type":"EXPERIMENTAL","interventionNames":["Drug: Imiquimod 5% cream"]}],"interventions":[{"name":"Imiquimod 5% cream","otherNames":["Aldara (imiquimod) 5% cream - 250 mg / packet"]}],"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n* Have at least 1 previously untreated superficial basal cell carcinoma tumor\n* Minimum tumor size 0.5 cm2 and maximum diameter of 2.0 cm\n\nExclusion Criteria:\n\n* Evidence of clinically significant, unstable medical conditions\n* Cannot have recent use of topical steroids or retinoids in the treatment area.","healthyVolunteers":false,"sex":"ALL","minimumAge":"18 Years","stdAges":["ADULT","OLDER_ADULT"]},"locations":{"multicenter":true},"periods":[],"outcomeMeasures":[{"type":"PRIMARY","title":"Number of Participants With Sustained Clearance Rate of Superficial Basal Cell Carcinoma (sBCC)","description":"Number of participants clinically clear of superficial basal cell carcinoma at the treated target tumor site at the 12-week posttreatment visit (ie, initial clearance rate) who remain clear during a 5 year follow-up period.","paramType":"NUMBER","dispersionType":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"119","spread":null}]}]}]},{"type":"SECONDARY","title":"Number of Participants Cleared of Superficial Basal Cell Carcinoma at 12 Weeks","description":"Number of participants cleared at 12 weeks(the number of subjects with no clinical evidence of superficial basal cell carcinoma at the target tumor site at the 12-week posttreatment visit)","paramType":"NUMBER","dispersionType":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"159","spread":null}]}]}]}],"adverseEventsModule":{"adverseEventsSummary":{"seriousAny":{"events":23,"n":169},"commonTop":["Application site reaction","Headache","Pain","Rhinitis"]}}}